W. Schgoer

发表

Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide–Dependent Mechanism

S. Rong, F. Bahlmann, R. Kirchmair, 2009, Circulation research.

The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice

M. Rudling, C. Fiévet, J. Patsch, 2010, PloS one.

Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

M. Rudling, C. Fiévet, J. Patsch, 2008, Endocrinology.

The effect of omega-3 fatty acids on coronary atherosclerosis quantified by coronary computed tomography angiography.

G. Feuchtner, G. Widmann, F. Plank, 2020, Clinical nutrition.

The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.

H. Ulmer, T. Mueller, M. Haltmayer, 2008, Clinical biochemistry.

Nilotinib-induced vasculopathy : identification of vascular 1 endothelial cells as a primary target site 2 3 4

G. Superti-Furga, U. Rix, P. Valent, 2017 .

Phospholipid Transfer Protein Augments Apoptosis in THP-1–Derived Macrophages Induced by Lipolyzed Hypertriglyceridemic Plasma

A. Hermetter, B. Foeger, M. Morak, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model

A. Bernkop‐Schnürch, R. Kirchmair, M. Theurl, 2017, Journal of controlled release : official journal of the Controlled Release Society.

The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism

S. Rong, S. Mahata, F. Bahlmann, 2010, Circulation research.

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

R. Kirchmair, P. Tymoszuk, I. Tancevski, 2015, Cardiovascular research.

The role of apolipoprotein A5 in non-alcoholic fatty liver disease

H. Tilg, A. Moschen, S. Kaser, 2011, Gut.

Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis.

B. Foeger, M. Jauhiainen, C. Ehnholm, 2008, Atherosclerosis.

Influence of aspirin on SR-BI expression in human carotid plaques.

B. Foeger, J. Patsch, Julia Huber, 2009, Atherosclerosis.

Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I

C. Fiévet, J. Patsch, P. Eller, 2005, Journal of Molecular Medicine.

Infarction by Stimulation of VEGF Signaling in Endothelial Cells The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial

R. Kishore, O. Pachinger, R. Kirchmair, 2012 .

Reduced Plasma HDL Cholesterol in Hyperthyroid Mice Coincides with Decreased Hepatic ABCA1 Expression

M. Rudling, C. Fiévet, J. Patsch, 2012 .

The thyromimetic T-0681 protects from atherosclerosis.

B. Foeger, M. Rudling, C. Fiévet, 2009, Journal of lipid research.

Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML

G. Superti-Furga, P. Valent, W. Sperr, 2013 .

Hepatic lipase polymorphism and increased risk of peripheral arterial disease

B. Foeger, H. Ulmer, T. Mueller, 2005, Journal of internal medicine.

Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver.

B. Foeger, J. Patsch, P. Eller, 2004, Journal of lipid research.

Scavenger receptor class B type I polymorphisms and peripheral arterial disease.

T. Mueller, M. Haltmayer, J. Patsch, 2007, Metabolism: clinical and experimental.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Monocyte migration: a novel effect and signaling pathways of catestatin.

J. Marksteiner, S. Mahata, R. Kirchmair, 2008, European journal of pharmacology.

The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells

R. Kishore, O. Pachinger, R. Kirchmair, 2012, Circulation.

Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization

R. Kirchmair, W. Franz, M. Theurl, 2013, PloS one.

Aspirin regulates expression and function of scavenger receptor‐BI in macrophages: studies in primary human macrophages and in mice

S. Cuzzocrea, B. Foeger, J. Patsch, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Hypoxia up‐regulates the angiogenic cytokine secretoneurin via an HIF‐1α‐ and basic FGF‐dependent pathway in muscle cells

G. Gurtner, Johannes Leierer, Douglas Losordo, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification

Elisabeth Naschberger, P. Heinrich, C. Ebenbichler, 2004, Clinical chemistry and laboratory medicine.

Evaluation of right ventricular function by coronary computed tomography angiography using a novel automated 3D right ventricle volume segmentation approach: a validation study

G. Feuchtner, F. Plank, E. Williamson, 2018, European Radiology.

The K121Q polymorphism of ENPP1 and peripheral arterial disease

T. Mueller, M. Haltmayer, J. Patsch, 2008, Heart and Vessels.

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site

G. Superti-Furga, U. Rix, P. Valent, 2017, Leukemia.

Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF

R. Kirchmair, W. Franz, U. Stanzl, 2013, Angiogenesis.

Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy

R. Kirchmair, U. Stanzl, M. Theurl, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.

The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.

H. Ulmer, T. Mueller, M. Haltmayer, 2008, Clinical Biochemistry.

Hepatic ENPP1 expression is induced in diabetic rabbits

J. Patsch, P. Eller, I. Tancevski, 2006, Mammalian Genome.

Hypoxia up‐regulates the angiogenic cytokine secretoneurin via an HIF‐1α‐ and basic FGF‐dependent pathway in muscle cells

G. Gurtner, Johannes Leierer, Douglas Losordo, 2007, The FASEB Journal.

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

R. Kirchmair, P. Tymoszuk, I. Tancevski, 2015, Cardiovascular research.

W15-P-007 Influence of aspirin on expression and function of scavenger receptor-BI within primary human macrophages: A new atheroprotective mechanism of aspirin?

B. Foeger, J. Patsch, P. Eller, 2005 .